Infant Bacterial Therapeutics AB .../ SE0008015259 /
2024-05-10 12:00:00 AM | Chg. +4.00 | Volume | Bid5:29:44 PM | Ask5:29:44 PM | High | Low |
---|---|---|---|---|---|---|
93.00SEK | +4.49% | 8,483 Turnover: 667,763.40 |
93.00Bid Size: - | 94.60Ask Size: - | 94.80 | 89.00 |
GlobeNewswire
2019-01-31
Gastrointestinal Diseases Pipeline Review, 2018 - Which Companies are the Most Active within Each Pi...
GlobeNewswire
2018-02-28
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 - December 31, 2017
GlobeNewswire
2018-01-10
Prospectus relating to Infant Bacterial Therapeutics' rights issue published
GlobeNewswire
2017-12-11
Infant Bacterial Therapeutics presents data from its Safety and Tolerability Study in premature infa...
GlobeNewswire
2017-11-24
Infant Bacterial Therapeutics announces capital raise of approximately SEK 545 million in total
GlobeNewswire
2017-11-23
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 - September 29, 2017
GlobeNewswire
2017-11-08
Infant Bacterial Therapeutics AB (publ) announces that the Nomination Committee is appointed for the...
GlobeNewswire
2017-09-28
European Medicines Agency adopts a positive opinion on the Paediatric Investigation Plan for IBT's l...
GlobeNewswire
2017-09-11
Infant Bacterial Therapeutics announces that top line data demonstrate similar safety and tolerabili...
GlobeNewswire
2017-08-28
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 - June 30, 2017
GlobeNewswire
2017-05-04
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 - March 31, 2017
GlobeNewswire
2017-04-06
Infant Bacterial Therapeutics AB (publ) Annual Report for 2016 has now been published
GlobeNewswire
2017-03-10
Infant Bacterial Therapeutics AB (publ), (IBT) has been approved for listing on Nasdaq First North's...
GlobeNewswire
2017-02-14
Infant Bacterial Therapeutics AB (publ), (IBT) Interim report January 1 - December 31 2016